Acesis Holdings Corpの企業情報（従業員数・代表者名など）
最終更新日：2024年6月12日
特色
Acesis Holdings Corp is a United States-based company. The Company operates as pre-phase I (first-in-man (FIM) clinical, biotechnology company focused on men’s health. The Company develops treatments for low testosterone levels in males (Low-T) known as T-deficiency or male hypogonadism. Its business model is to develop non-steroid product candidates that transform the treatment of men with Low-T. The Company’s lead peptide, ACE-167, has been designed to act through a molecular mechanism to induce the Leydi
企業情報
| 英文社名 | Acesis Holdings Corp |
|---|---|
| 本社所在地 | 9233 Park Meadows Rive, Suite 108 LONE TREE, CO 80124 USA |
| 電話番号 | 720 389-0650 |
| 設立年月 | 2022年1月 |
| 代表者名 | Konstantinos Karatzas |
| 業種名 | 医療関連（Health Care） |
| 市場名 | --- |
| 従業員数 | --- |
| ウェブサイト | --- |
